![Mark Eccleston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Eccleston
Chief Executive Officer at
VALIRX PLC
Net worth: 222 882 $ as of 31/05/2026
Profile
Mark Edward Eccleston was the founder of Vivamer Ltd. (founded in 2002, title: Chief Scientific Officer) and Volition, Inc. (founded in 1997, title: Director-Business Development).
Current jobs include Chief Executive Officer & Director at ValiRx Plc (starting in 2024) and Managing Director & Director at Oncolytika Ltd. (starting in 2010).
Former jobs include Director at ADD Signs Ltd. (2010-2017) and Chief Technology Officer at VolitionRX Ltd. (2021-2024).
Education includes an MBA from the University Of Dundee (conferral date: 2008) and a doctorate from the University of Aston (conferral date: 1998).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VALIRX PLC 11.41% | 20/05/2026 | 84,746,187 ( 11.41% ) | 222 882 $ | 31/05/2026 |
Mark Eccleston active positions
| Companies | Position | Start |
|---|---|---|
| VALIRX PLC | Chief Executive Officer | 12/08/2024 |
Volition, Inc.
 Volition, Inc. Packaged SoftwareTechnology Services Develops software and games for PC computers | Founder | 14/03/1997 |
Oncolytika Ltd.
 Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an technical consultancy company providing research and development services in biotechnology | Chief Executive Officer | 01/06/2010 |
Former positions of Mark Eccleston
| Companies | Position | End |
|---|---|---|
| VOLITIONRX LIMITED | Chief Tech/Sci/R&D Officer | 01/01/2024 |
ADD Signs Ltd.
 ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing Designs and manufactures signs and provides sign fabrication & installation, vinyl graphics and printing services | Director/Board Member | 03/02/2017 |
Vivamer Ltd.
 Vivamer Ltd. BiotechnologyHealth Technology Manufactures drugs based on biopolymer chemistry | Chief Executive Officer | - |
Training of Mark Eccleston
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
ValiRx Plc
 ValiRx Plc Pharmaceuticals: MajorHealth Technology Develops novel technologies and products in oncology therapeutics and diagnostics | Health Technology |
Volition, Inc.
Volition, Inc. Packaged SoftwareTechnology Services Develops software and games for PC computers | Technology Services |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivamer Ltd.
Vivamer Ltd. BiotechnologyHealth Technology Manufactures drugs based on biopolymer chemistry | Health Technology |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
ADD Signs Ltd.
ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing Designs and manufactures signs and provides sign fabrication & installation, vinyl graphics and printing services | Producer Manufacturing |
Oncolytika Ltd.
Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an technical consultancy company providing research and development services in biotechnology | Commercial Services |
- Stock Market
- Insiders
- Mark Eccleston
